Advisory Committee on Complementary Medicines (ACCM)
Role of the ACCM
The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the Therapeutic Goods Administration (TGA) on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.
The Committee is established under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health. Further information on membership (including the chair) of the ACCM will be provided in early 2017.
ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.
Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.
2017 ACCM proposed meeting dates
|Meeting no.||Meeting dates|
|17||16 June 2017|
|18||15 September 2017|
|19||8 December 2017|
Contact details for the ACCM
|Phone||+61 2 6232 8734|
|Fax||+61 2 6203 1250|
|Postal Address||Advisory Committee on Complementary Medicines
Department of Health
GPO Box 9848
Canberra ACT 2601